Verona Pharma plc logo
Verona Pharma plc VRNA

Quarterly report 2025-Q2
added 08-06-2025

report update icon

Verona Pharma plc Cash Conversion Cycle 2011-2026 | VRNA

Annual Cash Conversion Cycle Verona Pharma plc

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
136 - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
136 136 136

Quarterly Cash Conversion Cycle Verona Pharma plc

2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
64.2 56 - - - - - - - - - - - - - 28.5 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
64.2 28.5 49.6

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
209 $ 9.13 -0.76 % $ 591 M usaUSA
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
-400 $ 0.91 2.42 % $ 6.69 M chinaChina
Edesa Biotech Edesa Biotech
EDSA
97.1 $ 15.52 -2.39 % $ 49.6 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
257 $ 22.47 1.19 % $ 3.72 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Fortress Biotech Fortress Biotech
FBIO
-74.9 $ 2.24 0.9 % $ 62.5 M usaUSA
Galapagos NV Galapagos NV
GLPG
67.1 $ 28.07 0.75 % $ 2.69 B belgiumBelgium
Advaxis Advaxis
ADXS
-143 K - -9.65 % $ 45.9 M usaUSA
Grifols, S.A. Grifols, S.A.
GRFS
0.000171 $ 8.2 3.6 % $ 6.83 B spainSpain
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
20.4 $ 31.01 -0.13 % $ 1.78 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
ImmuCell Corporation ImmuCell Corporation
ICCC
213 $ 8.44 - $ 76.2 M usaUSA
Immuron Limited Immuron Limited
IMRN
867 $ 0.83 3.44 % $ 6.55 M australiaAustralia
Incyte Corporation Incyte Corporation
INCY
-54.7 $ 98.87 -0.23 % $ 19.3 B usaUSA
InMed Pharmaceuticals InMed Pharmaceuticals
INM
184 $ 0.71 1.28 % $ 1.74 M canadaCanada
INmune Bio INmune Bio
INMB
19.9 K $ 1.35 1.5 % $ 33.4 M usaUSA
Innoviva Innoviva
INVA
24.6 $ 23.13 0.35 % $ 1.56 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
Jaguar Health Jaguar Health
JAGX
289 $ 7.55 -4.13 % $ 17.6 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
-816 $ 26.67 -0.02 % $ 1.44 B britainBritain
Kamada Ltd. Kamada Ltd.
KMDA
163 $ 8.15 0.49 % $ 260 M israelIsrael
Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals Incorporated
LGND
77.8 $ 223.98 -0.39 % $ 4.1 B usaUSA
Liquidia Corporation Liquidia Corporation
LQDA
65.5 $ 38.39 0.62 % $ 3.3 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-2.85 K - -11.43 % $ 502 K usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
-172 $ 4.08 0.74 % $ 436 M usaUSA